Pharmaceutical Research

, Volume 11, Issue 3, pp 402–406 | Cite as

Enhanced Hepatic Uptake of Liposomes Through Complement Activation Depending on the Size of Liposomes

  • Hideyoshi Harashima
  • Kazuya Sakata
  • Kouichi Funato
  • Hiroshi Kiwada


The objective of this study was to differentiate the roles of opsonins and phagocytic cells in the size-dependent hepatic uptake of liposomes in the submicron region. The extent of opsonization decreased with the decrease in size of liposomes (from 800 to 200 nm in diameter) and no enhancement of uptake was observed at 200 nm. There was no effect of liposome size on the uptake of unopsonized liposomes. Serum was pretreated with empty liposomes of each size and its opsonic activity was measured in the perfused liver. The small liposomes could not consume the opsonic activity, while the larger ones did so substantially. These results suggest that opsonins bind to liposomes depending on the size of liposomes and phagocytic cells take up liposomes in proportion to the extent of opsonization. Size-dependent liposome degradation in serum was also found, which was consistent with the size-dependent complement activation, because liposomes with this composition have been shown to be degraded by complement. The mechanism of opsonization was examined by treating serum at 56°C for 30 min or with anti-C3 antiserum. Since both treatments inhibited the opsonic activity, the hepatic uptake of liposomes is considered to occur via complement receptor. In conclusion, the size of liposomes affected complement recognition, and the liposomes were taken up by the liver depending on the extent of opsonization.

liposomes opsonin size phagocytosis endocytosis complement receptor 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    D. P. Dalen, A. Brouwer, and D. L. Knook. Clearance capacity of rat liver Kupffer, endothelial, and parenchymal cells. Gastroenterology 81:1036–1044 (1981).Google Scholar
  2. 2.
    T. Nishi, A. Bhan, A. B. Collins, and R. T. McCluskey. Effect of circulating immune complexes on Fc and C3 receptors of Kupffer cells in vivo. Lab. Invest. 44:442–448 (1981).Google Scholar
  3. 3.
    K. N. Ekdahl, L. Loof, U. R. Nilsson, and B. Nilsson. An improved method to study complement receptor-mediated function of the fixed macrophage system in vivo. Vox Sang 61:47–52 (1991).Google Scholar
  4. 4.
    R. T. Sawyer, M. N. Horst, R. E. Garner, J. Hudson, P. R. Jenkins, and A. L. Richardson. Altered hepatic clearance and killing of Candida albicans in the isolated perfused mouse liver model. Infect. Immun. 58:2869–2874 (1990).Google Scholar
  5. 5.
    S. H. Gregory, L. K. Barczynski, and E. J. Wing. Effector function of hepatocytes and Kupffer cells in the resolution of systemic bacterial infections. J. Leu. Biol. 51:421–424 (1992).Google Scholar
  6. 6.
    C. R. Gardner, A. J. Wasserman, and D. L. Laskin. Liver macrophage-mediated cytotoxicity toward mastocytoma cells involves phagocytosis of tumor targets. Hepatology 14:318–324 (1991).Google Scholar
  7. 7.
    J. Darnell, H. Lodish, and D. Baltimore. The internalization of macromolecules and particles. In Molecular Cell Biology, 2nd ed., Scientific American Books, New York, 1990, pp. 555–582.Google Scholar
  8. 8.
    M. K. Pratten and J. B. Lloyd. Pinocytosis and phagocytosis: The effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro. Biochim. Biophys. Acta 881:307–313 (1986).Google Scholar
  9. 9.
    R. M. Steinman, S. E. Brodie, and Z. A. Cohn. Membrane flow during pinocytosis: A stereologic analysis. J. Cell Biol. 68:665–687 (1976).Google Scholar
  10. 10.
    E. J. Brown. Complement receptors and phagocytosis. Curr. Opin. Immun. 3:76–82 (1991).Google Scholar
  11. 11.
    H. Metzger. Fc receptors and membrane immunoglobulin. Curr. Opin. Immun. 3:40–46 (1991).Google Scholar
  12. 12.
    G. Gregoriadis. Fate of injected liposomes: observations on entrapped solution, vesicle clearance and tissue distribution in vivo. In G. Gregoriadis (ed.), Liposomes as Drug Carriers, John Wiley & Sons, New York, 1988, pp. 3–18.Google Scholar
  13. 13.
    R. M. Abra and C. A. Hunt. Liposome disposition in vivo III. Dose and vesicle-size effects. Biochim. Biophys. Acta 666:493–503 (1981).Google Scholar
  14. 14.
    Y. E. Rahman, E. A. Cerny, K. R. Patel, E. H. Lau, and B. J. Wright. Differential uptake of liposomes varying in size and lipid composition by parenchymal and Kupffer cells of mouse liver. Life Sci. 31:2061–2071 (1982).Google Scholar
  15. 15.
    T. M. Allen and J. M. Everest. Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats. J. Pharm. Exp. Ther. 226:539–544 (1983).Google Scholar
  16. 16.
    H. Harashima, K. Sakata, and H. Kiwada. Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic uptake of liposomes. Pharm. Res. 10:606–610 (1993).Google Scholar
  17. 17.
    H. Harashima, Y. Ohnishi, and H. Kiwada. In vivo evaluation of the effect of the size and opsonization on the hepatic extraction of liposomes in rats: An application of Oldendorf method. Biopharm. Drug Disp. 13:549–553 (1992).Google Scholar
  18. 18.
    K. Funato, R. Yoda, and H. Kiwada. Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidyl choline in rat fresh plasma. Biochim. Biophys. Acta 1103:198–204 (1992).Google Scholar
  19. 19.
    Z. Liu, R. Solow, and V. W. Hu. Fluorescence analysis of size distribution and mode of dye release from carboxyfluorescein-loaded vesicles: Application to the study of complement-membrane interactions. Biochim. Biophys. Acta 945:253–262 (1988).Google Scholar
  20. 20.
    J. T. P. Derksen, H. W. M. Morselt, and G. L. Scherphof. Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages. Biochim. Biophys. Acta 971:127–136 (1988).Google Scholar
  21. 21.
    W. Miyazaki, H. Tamaoka, M. Shinohara, H. Kaise, T. Izawa, Y. Nakano, T. Kinoshita, K. Hong, and K. Inoue. A complement inhibitor produced by Stachybotrys complementi, nov. sp. K-76, a new species of fungiimperfecti. Microbiol. Immunol. 24:1091–1108 (1980).Google Scholar
  22. 22.
    S. D. Wright and P. A. Detmers. Receptor-mediated phagocytosis. In R. G. Crystal and J. B. West (eds.), The Lung, Raven Press, New York, 1991, pp. 539–551.Google Scholar
  23. 23.
    H. M. Patel. Serum opsonins and liposomes: Their interaction and opsonophagocytosis. Crit. Rev. Ther. Drug Carr. Syst. 9:39–90 (1992).Google Scholar
  24. 24.
    C. Bianco, F. M. Griffin, and S. C. Silverstein. Studies of the macrophage complement receptor: Alteration of receptor function upon macrophage activation. J. Exp. Med. 141:1278–1290 (1975).Google Scholar
  25. 25.
    S. D. Wright and S. C. Silverstein. Tumor-promoting phorbol esters stimulate C3b and C3b receptor-mediated phagocytosis in cultured human monocytes. J. Exp. Med. 156:1149–1164 (1982).Google Scholar
  26. 26.
    J. F. Scieszka, L. L. Maggiora, S. D. Wright, and M. J. Cho. Role of complements C3 and C5 in the phagocytosis of liposomes by human neutrophils. Pharm. Res. 8:65–69 (1991).Google Scholar
  27. 27.
    A. Helenius, J. Kartenbeck, K. Simons, and E. Fries. On the entry of semliki forest virus into BHK-21 cells. J. Cell Biol. 84:404–420 (1980).Google Scholar
  28. 28.
    A. Takeda, C. U. Tuazon, and F. A. Ennis. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 242:580–583 (1988).Google Scholar
  29. 29.
    M. S. Brown and J. L. Goldstein. Receptor-mediated endocytosis: Insights from the lipoprotein receptor system. Proc. Natl. Acad. Sci. USA 76:3330–3337 (1979).Google Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • Hideyoshi Harashima
    • 1
  • Kazuya Sakata
    • 1
  • Kouichi Funato
    • 1
  • Hiroshi Kiwada
    • 1
  1. 1.Faculty of Pharmaceutical SciencesThe University of TokushimaJapan

Personalised recommendations